GigaWiper is a destructive backdoor that combines multiple wiping and ransomware-like capabilities into a single operational ...

On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...

Stack has been gauging interest and is preparing to start a sale process as soon as July. — Bloomberg NEW YORK: The Artificial Intelligence Infrastructure Partnership (AIP) and Brookfield Asset ...

Members of the Danville-Pittsylvania Regional Industrial Facility Authority unanimously approved a local performance agreement Monday with Denver-based data center developer and operator Stack ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Abstract: Ray tracing is widely used to generate photorealistic images by tracing the paths of light rays through a scene and their interactions with scene objects. To accelerate ray tracing, an ...

May 6 (Reuters) - Stack Infrastructure, a data centre firm owned by Blue Owl Capital, is considering its options, including a sale of its Asia operations in a deal valued at more ‌than $30 billion, ...

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

CINCINNATI—Late at night, or when her 18-month-old daughter is napping, Jessica Sharp logs onto Chat GPT and asks it to help her in her fight to stop a data center from being built just steps away ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...